Last update 08 May 2025

DAC-0060

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
+ [1]
Target
HDACs
Action
inhibitors
Mechanism
HDAC inhibitors(Histone deacetylase inhibitors)
Therapeutic Areas
Neoplasms
Active Indication-
Inactive Indication
Basal Cell Carcinoma
Originator Organization
Dac Research
Active Organization-
Inactive Organization
Dac Research
License Organization-
Drug Highest PhasePendingPhase 2
First Approval Date-
Regulation-

Related

1
Clinical Trials associated with DAC-0060
EUCTR2013-003336-72-IT
/ Unknown statusNot Applicable
A Phase IIb study of topic DAC-0060, a synthetic histone deacetylase inhibitor, plus Tazarotene in patients with cutaneous basal cell carcinoma (BCC)
100 Clinical Results associated with DAC-0060
Login to view more data
100 Translational Medicine associated with DAC-0060
Login to view more data
100 Patents (Medical) associated with DAC-0060
Login to view more data
100 Deals associated with DAC-0060
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Basal Cell CarcinomaPhase 2
Italy
Dac Research
20 Nov 2013
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free